A handful of newly identified mutations may contribute to the development of kidney cancer, a Nature paper suggests.
Patients with clear cell renal cell carcinoma, the most common form of adult kidney cancer, frequently carry a mutation in the VHL gene. However, a large sequencing study of DNA of more than 3,500 genes from around 100 tumour samples highlights the presence of mutations in a variety of other genes.
Three of these genes are involved in modifying proteins called histones, which help package DNA into chromosomes in the nucleus and have a role in gene regulation. Recurrent mutations in the NF2 gene, which encodes a tumour suppressor protein, are also noted.
The study, by Andrew Futreal and colleagues, hints that a variety of different genetic subtypes may contribute to kidney cancer, and highlights the value of large-scale sequencing studies in uncovering genetic diversity.
Article DOI: 10.1038/nature08672
The World Cancer Declaration recognises that to make major reductions in premature deaths, innovative education and training opportunities for healthcare workers in all disciplines of cancer control need to improve significantly.
ecancer plays a critical part in improving access to education for medical professionals.
Every day we help doctors, nurses, patients and their advocates to further their knowledge and improve the quality of care. Please make a donation to support our ongoing work.
Thank you for your support.